1. Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer
   Takahiro Tsuji et al, 2017, Oncotarget CrossRef
2. Inhibitory effects of tetrandrine on epidermal growth factor-induced invasion and migration in HT29 human colorectal adenocarcinoma cells
   CHI-TING HORNG et al, 2016, Molecular Medicine Reports CrossRef
3. Hexane Fraction of Adenophora triphylla var. japonica Root Extract Inhibits Angiogenesis and Endothelial Cell-Induced Erlotinib Resistance in Lung Cancer Cells
   Hyun-Ji Park et al, 2024, Molecules CrossRef
4. Abnormal activation of NF‐κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid‐derived suppressor cells to shape the immunosuppressive tumor immune microenvironment
   Chao Wang et al, 2023, Thoracic Cancer CrossRef
5. Natural products for combating multidrug resistance in cancer
   Ting Chen et al, 2024, Pharmacological Research CrossRef
6. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway
   Qing-yong Chen et al, 2016, Oncotarget CrossRef
7. MiR-144-3p inhibits the proliferation and metastasis of lung cancer A549 cells via targeting HGF
   Guiju Fang et al, 2022, Journal of Cardiothoracic Surgery CrossRef
8. Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer
   Cong Zhao et al, 2023, BMC Cancer CrossRef
9. Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge
   Tomomi Nakamura et al, 2017, Oncology Letters CrossRef
10. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers
    Fatemeh Moosavi et al, 2019, Critical Reviews in Clinical Laboratory Sciences CrossRef
11. Extensive serum biomarker analysis in patients with non-small-cell lung carcinoma
    Donghao Cai et al, 2020, Cytokine CrossRef
12. TargetingHGFwith Antibodies as an Anti‐Cancer Therapeutic Strategy
    Dinuka M. De Silva et al, 2018, Extracellular Targeting of Cell Signaling in Cancer CrossRef
13. TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer
    Vinod Kumar et al, 2024, Oncogene CrossRef
14. Hepatocyte growth factor/MET in cancer progression and biomarker discovery
    Kunio Matsumoto et al, 2017, Cancer Science CrossRef
15. Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met/PI3K/Akt signaling pathway
    Wei Gao et al, 2018, Biomedicine & Pharmacotherapy CrossRef
16. Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer
    Demin Jiao et al, 2016, Molecular Therapy - Oncolytics CrossRef